However, to date, no study has systematically evaluated and compared the performance of Non-HDL-C, AI, AIP, TG/HDL-C and lipid comprehensive index (LCI) in predicting the risk to T2DM. The gene discussed is AIP; the disease is type 2 diabetes mellitus.